Is a complete PROF research report available?

No complete published report is available for Profound Medical Corp. (PROF) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Profound Medical Corp. (PROF)

NASDAQ: PROF · USD

$5.81

+0.16 (+2.9%)· Recorded snapshot

Market cap	211M
Revenue (ttm)	19.1M
Net income (ttm)	-32.7M
EPS (ttm)	-$0.99
Shares out	36.5M
Volume	105,811
Beta	0.56

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.1M
Net income (ttm): -32.7M
EPS (ttm): -$0.99
Market cap: 211M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001628808
Company name	Profound Medical Corp.
Country	Canada
Country code	US
CUSIP number	74319B502
Earnings date	2026-11-05
Earnings time	amc
Employees	162
Employees change	20
Employees growth	14.08%
Enterprise value	$179.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Medical Devices
Is primary listing	No
Is SPAC	No
ISIN number	CA74319B5027
Last 10-K release date	2026-03-05
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-10-16
Last stock split type	Reverse
Market cap	$211M
Market cap category	Micro-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$5.81
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	PROF
Website	https://www.profoundmedical.com

Metric

Value

Amount currency

USD

CIK code

0001628808

Company name

Profound Medical Corp.

Country

Canada

Country code

CUSIP number

74319B502

Earnings date

2026-11-05

Earnings time

amc

Employees

162

Employees change

Employees growth

14.08%

Enterprise value

$179.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Industry

Medical Devices

Is primary listing

Is SPAC

ISIN number

CA74319B5027

Last 10-K release date

2026-03-05

Last earnings date

2026-08-06

Last refreshed

2026-10-28

Last stock split date

2019-10-16

Last stock split type

Reverse

Market cap

$211M

Market cap category

Micro-Cap

Next earnings date

2026-11-05

Options

Yes

Price

$5.81

Price currency

USD

Sector

Healthcare

SIC code

3841

Stock price date

2026-10-28

Symbol

PROF

Website

https://www.profoundmedical.com

Metric	Value
Earnings yield	-17.09%
EV/Sales	9.1x
FCF / EV yield	-20.88%
FCF yield	-17.7%
Forward EV/Sales	4.45x
Forward P/S	5.26x
Industry forward P/E	19.81x
Industry P/E	39.5x
P/B ratio	4.12x
P/S ratio	10.74x
Price / tangible book value	4.13x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-17.09%

EV/Sales

9.1x

FCF / EV yield

-20.88%

FCF yield

-17.7%

Forward EV/Sales

4.45x

Forward P/S

5.26x

Industry forward P/E

19.81x

Industry P/E

39.5x

P/B ratio

4.12x

P/S ratio

10.74x

Price / tangible book value

4.13x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-185.31%
EBITDA margin	-182.74%
Gross margin	71.79%
Operating margin	-185.31%
Pretax margin	-170.37%
Profit margin	-171.56%
Profit per employee	$-202,123
Revenue per employee	$117,815
ROA	-39.46%
ROA (5Y)	-29.68%
ROCE	-66.39%
ROE	-73.53%
ROE (5Y)	-54.72%
ROIC	-43.66%
SBC / revenue	26.05%
Tax / revenue	1.19%

Metric

Value

EBIT margin

-185.31%

EBITDA margin

-182.74%

Gross margin

71.79%

Operating margin

-185.31%

Pretax margin

-170.37%

Profit margin

-171.56%

Profit per employee

$-202,123

Revenue per employee

$117,815

ROA

-39.46%

ROA (5Y)

-29.68%

ROCE

-66.39%

ROE

-73.53%

ROE (5Y)

-54.72%

ROIC

-43.66%

SBC / revenue

26.05%

Tax / revenue

1.19%

Metric	Value
EPS growth quarters	2
EPS growth years	0
Gross profit growth	66.66%
Gross profit growth (Q)	20.33%
Gross profit growth 3Y	52.1%
Gross profit growth 5Y	27.39%
Net income growth quarters	2
Net income growth years	0
Revenue growth	61.2%
Revenue growth (Q)	12.3%
Revenue growth (QoQ)	-53.48%
Revenue growth 3Y	41.38%
Revenue growth 5Y	17.68%
Revenue growth quarters	4
Revenue growth years	3

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

66.66%

Gross profit growth (Q)

20.33%

Gross profit growth 3Y

52.1%

Gross profit growth 5Y

27.39%

Net income growth quarters

Net income growth years

Revenue growth

61.2%

Revenue growth (Q)

12.3%

Revenue growth (QoQ)

-53.48%

Revenue growth 3Y

41.38%

Revenue growth 5Y

17.68%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-176,000
Depreciation and amortization	$491,000
EBIT	$-35.4M
EBITDA	$-34.9M
EPS	$-0.99
FCF per share	$-0.99
Financing cash flow	$41.4M
Free cash flow	$-36.3M
Free cash flow minus SBC	$-41.2M
Gross profit	$13.7M
Income taxes	$227,000
Investing cash flow	$-242,000
Net cash flow	$3.1M
Net income	$-32.7M
Operating cash flow minus SBC	$-41.1M
Operating income	$-35.4M
Revenue	$19.1M
Stock-based compensation	$5M

Metric

Value

Capital expenditures

$-176,000

Depreciation and amortization

$491,000

EBIT

$-35.4M

EBITDA

$-34.9M

EPS

$-0.99

FCF per share

$-0.99

Financing cash flow

$41.4M

Free cash flow

$-36.3M

Free cash flow minus SBC

$-41.2M

Gross profit

$13.7M

Income taxes

$227,000

Investing cash flow

$-242,000

Net cash flow

$3.1M

Net income

$-32.7M

Operating cash flow minus SBC

$-41.1M

Operating income

$-35.4M

Revenue

$19.1M

Stock-based compensation

$5M

Metric	Value
Altman Z-Score	2.63
Book value per share	$1.36
Debt / equity	0.15
Long-term assets	$3.5M
Long-term liabilities	$3.5M
Net cash (debt)	$30.9M
Net cash / market cap	15.07%
Net cash growth	1.68%
Net debt / equity	-0.62
Piotroski F-Score	2
Property, plant and equipment	$3.3M
Shareholders' equity	$49.8M
Tangible book value	$49.7M
Tangible book value per share	$1.36
Total assets	$62.4M
Total cash	$38.3M
Total debt	$7.4M
Total liabilities	$12.6M
WACC	7.05%

Metric

Value

Altman Z-Score

2.63

Book value per share

$1.36

Debt / equity

0.15

Long-term assets

$3.5M

Long-term liabilities

$3.5M

Net cash (debt)

$30.9M

Net cash / market cap

15.07%

Net cash growth

1.68%

Net debt / equity

-0.62

Piotroski F-Score

Property, plant and equipment

$3.3M

Shareholders' equity

$49.8M

Tangible book value

$49.7M

Tangible book value per share

$1.36

Total assets

$62.4M

Total cash

$38.3M

Total debt

$7.4M

Total liabilities

$12.6M

WACC

7.05%

Metric	Value
Asset turnover	0.34
Current assets	$58.9M
Current liabilities	$9.1M
Current ratio	6.46
Inventory turnover	0.57
Net working capital	$16.1M
Quick ratio	5.25
Working capital	$49.8M
Working capital turnover	0.41

Metric

Value

Asset turnover

0.34

Current assets

$58.9M

Current liabilities

$9.1M

Current ratio

6.46

Inventory turnover

0.57

Net working capital

$16.1M

Quick ratio

5.25

Working capital

$49.8M

Working capital turnover

0.41

Metric	Value
Buyback yield / dilution	-20.87%
Dividend yield	0%
Shareholder yield	-20.87%

Metric

Value

Buyback yield / dilution

-20.87%

Dividend yield

Shareholder yield

-20.87%

Metric	Value
10Y price change	-27.04%
10Y return CAGR	-3.1%
10Y total return	-27.04%
150-day SMA	$6.66
1D price change	2.92%
1M price change	0.69%
1M total return	0.69%
1W price change	-2.03%
1W total return	-2.03%
1Y price change	5.46%
1Y return CAGR	5.46%
1Y total return	5.46%
20-day SMA	$6.11
200-day SMA	$6.69
3M price change	-20.87%
3M total return	-20.87%
3Y price change	-29.61%
3Y return CAGR	-11.04%
3Y total return	-29.61%
50-day SMA	$6.25
50-day SMA vs 200-day SMA	50under200
52-week high	$8.95
52-week high date	2026-01-13
52-week low	$4.80
52-week low date	2026-03-09
5Y price change	-56.78%
5Y return CAGR	-15.45%
5Y total return	-56.78%
6M price change	-14.07%
6M total return	-14.07%
All-time high	$28.97
All-time high date	2021-02-08
All-time low	$3.10
All-time low date	2022-10-26
Average true range (ATR)	$0.36
Average volume	332.8K
Beta (5Y)	0.56
Change from 52-week high	-35.08%
Change from 52-week low	21.04%
Change from all-time high	-79.98%
Change from all-time low	87.1%
Change from open	-0.34%
Day's gap	3.19%
Dollar volume	$614,762
High price	$5.89
Low price	$5.64
Monthly RSI	43.73
Open price	$5.83
Position in 52-week range	68%
Premarket change	0.8%
Premarket close	$5.65
Premarket price	$5.69
Previous close	$5.65
Price vs 150-day SMA	-12.89%
Price vs 20-day SMA	-5.14%
Price vs 200-day SMA	-13.32%
Price vs 50-day SMA	-7.21%
Relative volume	0.32
RSI	44.86
Sharpe ratio	0.37
Sharpe ratio (3Y)	0.05
Sharpe ratio (5Y)	0.01
Sortino ratio	0.63
Sortino ratio (3Y)	0.16
Sortino ratio (5Y)	0.11
Volume	105.8K
Weekly RSI	43.75
YTD price change	-26.3%
YTD total return	-26.3%

Metric

Value

10Y price change

-27.04%

10Y return CAGR

-3.1%

10Y total return

-27.04%

150-day SMA

$6.66

1D price change

2.92%

1M price change

0.69%

1M total return

0.69%

1W price change

-2.03%

1W total return

-2.03%

1Y price change

5.46%

1Y return CAGR

5.46%

1Y total return

5.46%

20-day SMA

$6.11

200-day SMA

$6.69

3M price change

-20.87%

3M total return

-20.87%

3Y price change

-29.61%

3Y return CAGR

-11.04%

3Y total return

-29.61%

50-day SMA

$6.25

50-day SMA vs 200-day SMA

50under200

52-week high

$8.95

52-week high date

2026-01-13

52-week low

$4.80

52-week low date

2026-03-09

5Y price change

-56.78%

5Y return CAGR

-15.45%

5Y total return

-56.78%

6M price change

-14.07%

6M total return

-14.07%

All-time high

$28.97

All-time high date

2021-02-08

All-time low

$3.10

All-time low date

2022-10-26

Average true range (ATR)

$0.36

Average volume

332.8K

Beta (5Y)

0.56

Change from 52-week high

-35.08%

Change from 52-week low

21.04%

Change from all-time high

-79.98%

Change from all-time low

87.1%

Change from open

-0.34%

Day's gap

3.19%

Dollar volume

$614,762

High price

$5.89

Low price

$5.64

Monthly RSI

43.73

Open price

$5.83

Position in 52-week range

68%

Premarket change

0.8%

Premarket close

$5.65

Premarket price

$5.69

Previous close

$5.65

Price vs 150-day SMA

-12.89%

Price vs 20-day SMA

-5.14%

Price vs 200-day SMA

-13.32%

Price vs 50-day SMA

-7.21%

Relative volume

0.32

RSI

44.86

Sharpe ratio

0.37

Sharpe ratio (3Y)

0.05

Sharpe ratio (5Y)

0.01

Sortino ratio

0.63

Sortino ratio (3Y)

0.16

Sortino ratio (5Y)

0.11

Volume

105.8K

Weekly RSI

43.75

YTD price change

-26.3%

YTD total return

-26.3%

Metric	Value
Float	35.5M
Float percentage	97.18%
Shares change (QoQ)	0.15%
Shares change (YoY)	20.87%
Shares held by insiders	2.82%
Shares held by institutions	50.57%
Shares outstanding	36.5M
Short % of float	4.39%
Short % of shares	4.26%
Short ratio	11.8 days

Metric

Value

Float

35.5M

Float percentage

97.18%

Shares change (QoQ)

0.15%

Shares change (YoY)

20.87%

Shares held by insiders

2.82%

Shares held by institutions

50.57%

Shares outstanding

36.5M

Short % of float

4.39%

Short % of shares

4.26%

Short ratio

11.8 days

Profound Medical Corp. (PROF)

Price

Financial snapshot

Fair-value bridge

Latest news · PROF

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PROF indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on PROF

Frequently asked questions